SEC Form 4 · accession 0001364954-18-000204
CHEGG, INC · CHGG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Rosensweig
Officer — PRESIDENT, CEO & CHAIRMAN · Director
Period of report
Nov 12, 2018
Accepted (ET)
Nov 13, 2018 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001364954
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 12, 2018 | M | 100,000 | $7.875 | A | 2,435,450 | D | |
| Common StockF2 | Nov 12, 2018 | S | 100,000 | $26.36 | D | 2,335,450 | D | |
| Common Stock | Nov 12, 2018 | M | 25,000 | $7.875 | A | 2,360,450 | D | |
| Common StockF3 | Nov 12, 2018 | S | 25,000 | $26.31 | D | 2,335,450 | D | |
| Common Stock | Nov 12, 2018 | M | 25,000 | $7.875 | A | 2,360,450 | D | |
| Common StockF4 | Nov 12, 2018 | S | 25,000 | $26.31 | D | 2,335,450 | D | |
| Common StockF5 | holding | — | — | — | 69,346 | I | See footnote | |
| Common Stock | holding | — | — | — | 7,166 | I | By The Rachel Rosensweig 2007 Irrevocable Trust U/A/D 3-12-07 | |
| Common Stock | holding | — | — | — | 7,166 | I | By The Samantha Rosensweig 2007 Irrevocable Trust U/A?D 03-12-07 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F6 | $7.875 | Nov 12, 2018 | M | 100,000 | D | — | May 3, 2021 | Common Stock | 100,000 | 115,082 | D |
| Employee Stock Option (right to buy)F6 | $7.875 | Nov 12, 2018 | M | 25,000 | D | — | May 3, 2021 | Common Stock | 25,000 | 90,082 | D |
| Employee Stock Option (right to buy)F6 | $7.875 | Nov 12, 2018 | M | 25,000 | D | — | May 3, 2021 | Common Stock | 25,000 | 65,082 | D |
Explanation of responses
- F1The exercise of options and sale of the resultant shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.
- F2This transaction was executed in multiple trades at prices ranging from $25.69 to $26.92; the price reported above reflects the weighted average sale price. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares and prices at which the transactions were effected.
- F3This transaction was executed in multiple trades at prices ranging from $25.68 to $26.92; the price reported above reflects the weighted average sale price. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares and prices at which the transactions were effected.
- F4This transaction was executed in multiple trades at prices ranging from $25.67 to $26.92; the price reported above reflects the weighted average sale price. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares and prices at which the transactions were effected.
- F5Held by Daniel L and Linda Rosensweig, Co-Trustees of the Rosensweig Family Revocable Trust U/A/D 03-12-07. The Reporting Person is a Co-Trustee.
- F6The stock option grant is fully vested.